Erythropoietin as an antiapoptotic, tissue-protective cytokine
The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
Erythropoietin (EPO) increases the number of circulating erythrocytes primarily by preventing apoptosis of erythroid progenitors. In addition to this proerythroid action, results of recent studies show that systemically administered EPO is protective in vivo, in several animal models of neuronal injury. In vitro, EPO prevents neuronal apoptosis induced by a variety of stimuli. This review summarizes the neuroprotective actions of EPO and discusses the underlying mechanisms in terms of signal transduction pathways involved. The understanding of these mechanisms will help differentiate the neuroprotective actions of EPO from its role in the bone marrow.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Erythropoietin was originally recognized via its role in erythropoiesis [2145-2147] (hence its name, of course), but it has become evident that it has many other roles, and in particular it is observed phenomenologically that erythropoietin (and non-erthyropoetic derivatives) is protective in a number of inflammatory conditions that accompany many diseases such as those listed above [940,942,2148-”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [2149]
Citations
Cites
Structural design and molecular evolution of a cytokine receptor superfamily.
Bazan, J. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6934 · Cited by 2,069 · cited 1×
“cytokines of the IL-6 family (IL-6, leukemia inhibitory factor (LIF), ciliary neurotrophic factor (CNTF) and oncostatin M).(21,22)”
BackgroundNF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402
Self-citationVEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A. V., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17977 · Cited by 1,282
HIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,268
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317977 · Cited by 1,189
Wenger, R. H. (2002) · The FASEB Journal · doi:10.1096/fj.01-0944rev · Cited by 1,135 · cited 1×
“been suggested that, because HIF is often constitutively expressed in tumors, it may mediate the high constitutive expression of glycolytic enzymes that is the basis of the Warburg effect.(3,5)”
BackgroundErythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
Ehrenreich, H., Hasselblatt, M., Dembowski, C., Cepek, L., Lewczuk, P., Stiefel, M., Rustenbeck, H.-H., Breiter, N., Jacob, S., Knerlich, F., et al. (2002) · Molecular Medicine · doi:10.1007/bf03402029 · Cited by 1,028 · cited 1×
“of human stroke by EPO used three daily doses substantially higher than the clinical norm and, in these patients, EPO was shown to be safe and did not raise the hemoglobin concentration.(80) Thus, this might represent a valuable therapeutic approach to acute CNS injury, such as brain and spinal cord trauma.”
Self-citationErythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
Sirén, A.-L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051606598 · Cited by 1,019 · cited 3×
“Using a model of ischemia with reperfusion, it was shown that neurons within the penumbra would undergo apoptosis unless exposed to EPO within 3 h of injury.(39) In addition to this antiapoptotic effect, EPO administration is also associated with a marked decrease in proinflammatory cytokines within the hemisphere und…”
BackgroundMethodInfluentialSelf-citationOosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Dorpe, J. V., Hellings, P., Gorselink, M., Heymans, S., et al. (2001) · Nature Genetics · doi:10.1038/88842 · Cited by 1,007
Cited by
Items 201–300 of 336
Mouse (Mus musculus) embryonic cerebral cortex cell death caused by carbofuran insecticide exposure
Luqman, E. M., Sudiana, I. K., Darmanto, W., Achmad, A. B., & Widjiati, W. (2019) · Journal of Veterinary Research · doi:10.2478/jvetres-2019-0040 · Cited by 17
Pleiotropic effects of erythropoietin in neuronal and vascular systems
Boogaerts, M. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x159588 · Cited by 12
Miscellanea on Encephalopathies
Legname, G., & Zanusso, G. (2012) · InTech eBooks · doi:10.5772/1191 · Cited by 11
Chen, F., Xie, Z., Wu, X., Du, W., Wang, J., Zhu, J., Ji, H., & Wang, Y. (2012) · Current Eye Research · doi:10.3109/02713683.2012.713156 · Cited by 11
Indwelling stents cause obstruction and induce ureteral injury and fibrosis in a porcine model
Scotland, K. B., Almutairi, K., Park, E., Wang, L., Kung, S. H. Y., Haegert, A. M., Adomat, H. H., Bell, R. H., LeBihan, S., Chew, B. H., et al. (2022) · British Journal of Urology · doi:10.1111/bju.15912 · Cited by 11
Prognostic Value of HIF-1α-Induced Genes in Sepsis/Septic Shock
Lotsios, N. S., Keskinidou, C., Jahaj, E., Mastora, Z., Dimopoulou, I., Orfanos, S. E., Vassilaki, N., Vassiliou, A. G., & Kotanidou, Α. (2023) · Medical Sciences · doi:10.3390/medsci11020041 · Cited by 12
Core, A., Hempel, C., Kurtzhals, J. A. L., & Penkowa, M. (2010) · Experimental Parasitology · doi:10.1016/j.exppara.2010.09.010 · Cited by 14
Erythropoietin ameliorates the reduced migration of human fibroblasts during in vitro hypoxia
Breit, S., Bubel, M., Pohlemann, T., & Oberringer, M. (2010) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-010-0043-5 · Cited by 12
“EPO is a general antiinflammatory, anti-apoptotic and tissue protective factor [10, 22, 45].”
BackgroundRiehle, K. J., Hoagland, V. D., Benz, W., Campbell, J. S., Liggitt, D. H., & Langdale, L. A. (2014) · Shock · doi:10.1097/shk.0000000000000231 · Cited by 11
Abugri, J., Tetteh, J. K. A., Oseni, L. A., Mensah-Brown, H. E., Delimini, R., Obuobi, D. O., & Akanmori, B. D. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-551 · Cited by 11
“Previous studies have established the ability of erythropoietin to cross the blood/brain barrier and to provide protection against experimental injury as well as act as a tissue protective cytokine [13,14].”
BackgroundWang, H., Hsiao, C., Hsieh, A., Lin, Y., & Fann, C. S. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040996 · Cited by 10
“EPO has been shown to have multiple effects on neurons [59].”
BackgroundBeirão, J. M., Moreira, L., Oliveira, J. C. F., Menéres, M. J., Pessoa, B., Matos, M. E., Costa, P., Torres, P., & Beirão, I. B. (2014) · Europe PMC (PubMed Central) · Cited by 10
The cytokine receptor CRLF3 is a human neuroprotective EV-3 (Epo) receptor
Knorr, D. Y., Rodríguez-Polo, I., Pies, H. S., Schwedhelm‐Domeyer, N., Pauls, S., Behr, R., & Heinrich, R. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1154509 · Cited by 10
When Neuroprotection Becomes a Potential Ally of High-Grade Glioma
Grasso, G., & Torregrossa, F. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.02.086 · Cited by 10
Torregrossa, F., & Grasso, G. (2022) · World Neurosurgery · doi:10.1016/j.wneu.2021.11.096 · Cited by 10
Time- and Gender-Dependent Alterations in Mice during the Aging Process
Jin, J., Yang, X., Gong, H., & Li, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612790 · Cited by 11
Erythropoietin: an update on the therapeutic use in newborn infants and children
Donato, H. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.5.723 · Cited by 10
“Signalling through these receptors provides cytoprotection by different mechanisms, mainly inhibition of apoptosis (reviewed by Ghezzi and Brines [74] and studies referenced therin).”
BackgroundAsano, H., Fukunaga, S., Deguchi, Y., Kawamura, S., & Inaba, M. (2012) · The Journal of Toxicological Sciences · doi:10.2131/jts.37.23 · Cited by 10
“This induction of Bcl-xL has been proposed to be the primary mediator of the anti-apoptotic effect of EPO during erythroid maturation (Dolznig et al., 2002; Ghezzi and Brines, 2004).”
ZHAO, X.-F., Liu, Y., Zi-ming, H., & Xu, Y. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2419 · Cited by 9
“Erythropoietin is bone marrow stimulation factor, synthesized by the kidneys and liver, and a multifunctional member of the cytokine super family (29).”
Park, E., Cox, M., Scotland, K. B., Buttyan, R., & Lange, D. (2020) · Cell Stress and Chaperones · doi:10.1007/s12192-020-01067-3 · Cited by 9
The effect of erythropoietin to pulmonary injury and mast cells secondary to acute pancreatitis
Korkmaz, T., Kahramansoy, N., Kılıçgün, A., & Fırat, T. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-267 · Cited by 9
“By its receptors, EPO, as a cytokine has antiapoptotic and cytoprotective effects [5-7].”
BackgroundOrtiz, J. S. (2008) · Clinical & Translational Oncology · doi:10.1007/s12094-008-0237-2 · Cited by 9
Update on Erythropoiesis-Stimulating Agents Administered to Neonates for Neuroprotection
Maxwell, J. R., & Ohls, R. K. (2019) · NeoReviews · doi:10.1542/neo.20-11-e622 · Cited by 9
Mok, P. L., Cheong, S., Leong, C. F., Chua, K. H., & Ainoon, O. (2012) · Tissue and Cell · doi:10.1016/j.tice.2012.04.002 · Cited by 9
Erythropoietin attenuates hydrogen peroxide-induced damage of hepatocytes.
Yazıhan, N., Ataoğlu, H., Yener, B., & Aydın, C. (2007) · The Turkish Journal of Gastroenterology · Cited by 9
Mengozzi, M., Ermilov, P., Annenkov, A. E., Ghezzi, P., & Pearl, F. M. G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00115 · Cited by 8
Self-citationZhang, L., Wang, L., Yong, L. I., Li, W., Yan, H., Xin, L. I. U., Zhao, K., & Lixian, W. A. N. G. (2011) · Animal Science Journal · doi:10.1111/j.1740-0929.2011.00901.x · Cited by 8
Gobe, G. C., Endre, Z. H., & Johnson, D. W. (2007) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2007.07.001 · Cited by 8
Rousseau, N., Picot, S., & Bienvenu, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00502 · Cited by 7
“Among the potential cell protective drugs, erythropoietin (EPO) is one of the most promising drug due to its capacity to prevent programed cell death, to reduce the development of pro-inflammatory cytokine, and to enable tissue regeneration (10, 11).”
BackgroundRational engineering of an erythropoietin fusion protein to treat hypoxia
Lee, J., Vernet, A., Gruber, N. G., Kready, K. M., Burrill, D. R., Way, J. C., & Silver, P. A. (2021) · Protein Engineering Design and Selection · doi:10.1093/protein/gzab025 · Cited by 8
Erythropoietin in Spinal Cord Injury: Challenges for a novel neuroprotective strategy
Brines, M. L., & Cerami, A. (2006) · Springer eBooks · doi:10.1007/978-0-387-30011-5_9 · Cited by 7
Self-citationNagashima, T., Yokohama, A., Nagai, K., Kasamatsu, T., Gotoh, N., Iriuchishima, H., Sekigami, T., Saitoh, T., Handa, H., Tsukamoto, N., et al. (2018) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2018.01.009 · Cited by 7
Modulation of Immune Response by Head Injury
Morganti-Kossmann, C., Semple, B. D., Ziebell, J. M., Yan, E. B., Bye, N., & Kossmann, T. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384691-4.00010-9 · Cited by 9
Intranasal delivery systems for traumatic brain injury: Advancements and perspectives
Yoo, S. H., Heo, S. C., Bae, J. S., Lee, J. H., Knowles, J. C., & Kim, H. (2025) · Journal of Tissue Engineering · doi:10.1177/20417314251372373 · Cited by 7
“102,105 Following TBI, there is a marked upregulation of EPO receptor expression in neurons, glia, and endothelial cells, indicating a potential role in the endogenous repair response.”
Erythropoietin prevents lymphoid apoptosis but has no effect on survival in experimental sepsis
Köroğlu, T., Yılmaz, O., Gökmen, N., Tuğyan, K., Baskın, H., & Eğrilmez, M. Y. (2013) · Pediatric Research · doi:10.1038/pr.2013.86 · Cited by 6
Lim, J. W., & Han, J. R. (2011) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2011.02510.x · Cited by 6
“Growing evidence suggests that EPO has both neuroprotective and vascular protective functions in diabetic retinopathy.(40,41) Theoretically, increased EPO could lead to VEGF inhibition through enhanced HIF-1a feedback or to EPO reduction as a result of less neuronal and glial stress.”
BackgroundThrombopoietin limits IL-6 release but fails to attenuate liver injury in two hepatic stress models
Eipel, C., von Hardenberg, J., Negendank, S., Abshagen, K., & Vollmar, B. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32831f1f68 · Cited by 6
Carbamylated erythropoietin does not alleviate signs of dystrophy in mdx mice
Wu, M. P., & Gussoni, E. (2010) · Muscle & Nerve · doi:10.1002/mus.21785 · Cited by 6
“Several studies have highlighted EPO’s protective biological effects in organs other than the hematopoietic system.(25) It is hypothesized that these effects occur through EPO binding to the common beta receptor, a subunit of GM-CSF, IL-3, and IL-5 receptors.”
Does erythropoietin affect motility of spermatozoa?
Tuğ, N., Altunkaynak, M. E., Aktaş, R. G., Kılıç, Ü., Yılmaz, B., Çam, Ç., & Karateke, A. (2009) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-1289-4 · Cited by 6
OPTA: Optimal treatment of anaemia in patients with chronic kidney disease (CKD)
Hörl, W. H., Vanrenterghem, Y. F. C., Aljama, P., Brunet, P., Brunkhorst, R., Gesualdo, L., Macdougall, I. C., Wanner, C., & Wíkström, B. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm017 · Cited by 7
“ESA also has autocrine or paracrine actions, for example on the brain [49].”
BackgroundErythropoietin Prevents Dialysis Fluid-Induced Apoptosis of Mesothelial Cells
Vorobiov, M., Malki, M., Shnaider, A., Basok, A., Rogachev, B. V., Lewis, E. C., Chaimovitz, C., Zlotnik, M., & Douvdevani, A. (2008) · Peritoneal Dialysis International · doi:10.1177/089686080802800618 · Cited by 6
“These intracellular signaling pathways have been previously described in the literature as being the major signaling cascades of EPO in different types of cells (6,20,21).”
BackgroundMuttathukunnel, P., Wälti, M., Aboouf, M. A., Köster-Hegmann, C., Haenggi, T., Gassmann, M., Pannzanelli, P., Fritschy, J., & Gasser, E. M. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-46783-9 · Cited by 5
“Given that EPO is an anti-apoptotic cytokine 12 and that we previously showed that it promotes survival in hippocampal neurons during postnatal development 28 , we analyzed apoptosis (cleaved caspase 3) of Olig2+ cells of Cre+ and Cre− mice early at postnatal age P4.”
MethodTorbett, B. E., & Friedman, J. S. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8698-6_1 · Cited by 6
Neuroprotective Effects of Erythropoietin in Focal Brain Ischemia in Rats
Просвирнина, М. С., Шмонин, А. А., Мельникова, Е. В., & Vlasov, T. D. (2014) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-014-2415-2 · Cited by 5
Fauzi, I., Panoskaltsis, N., & Mantalaris, A. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0105 · Cited by 5
“number of CFU-E and erythroid precursors up to the stage of basophilic erythroblasts, mainly by preventing apoptosis [56].”
Pegka, F., Ben‐Califa, N., Neumann, D., Jäkel, H., & Hengst, L. (2023) · Cells · doi:10.3390/cells12131704 · Cited by 5
Die Rolle von Erythropoietin bei der Verbesserung der Wundheilung
Sorg, H., Kuhbier, J. W., Menger, B., Reimers, K., Harder, Y., & Vogt, P. (2010) · Der Chirurg · doi:10.1007/s00104-010-1978-3 · Cited by 5
Wagner, N., Musiychuk, K., Shôji, Y., Tottey, S., Streatfield, S. J., Fischer, R., & Yusibov, V. M. (2024) · Biotechnology Journal · doi:10.1002/biot.202300715 · Cited by 4
Clark, A. R., Mauntel, T. C., Goldman, S. M., & Dearth, C. L. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1105599 · Cited by 5
“Erythropoietin (epoetin alfa) is a multimodal therapeutic that stimulates red blood cells and has anti-apoptotic effects on a variety of tissues (Ghezzi and Brines, 2004).”
BackgroundIto, T., Kometani, K., Minato, N., & Hamazaki, Y. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901101 · Cited by 4
Does erythropoietin modulate human hair follicle melanocyte activities in situ?
Bodó, E., Wiersma, F., Funk, W., Kromminga, A., JELKMANN, W. E. B., & Paus, R. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00938.x · Cited by 4
Decreased circulatory erythropoietin in hyperacute phase of myocardial ischemia
Alioğlu, E., Ercan, E., Tamer, G. S., Duman, C., Türk, U. Ö., Tengiz, İ., Tüzün, N., & Saygı, S. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.12.184 · Cited by 4
History and Biology of Erythropoietin in Hematopoietic and Non-Neural Tissues
Melli, G., Keswani, S. C., & Höke, A. (2006) · Springer eBooks · doi:10.1007/978-0-387-30011-5_1 · Cited by 4
SINGH, A. K., GUPTA, S., Barnes, A. M. T., CARLSON, J. M., & Ayers, J. K. (2007) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2007.00828.x · Cited by 4
Current Opinions on Epidemiology, Treatment and Outcome After Traumatic Brain Injury
Urbanek, F., Frink, M., Grün, O., & Lohse, R. (2012) · Journal of Trauma & Treatment · doi:10.4172/2167-1222.1000s1-001 · Cited by 4
“Nevertheless, the potential risks of significant complications like infection, hygroma, oedema, haemorrhage and hydrocephalus [56] imply surgical treatment of intracranial hypertension in absence of mass lesions as last resort [59].”
BackgroundMarelli, A., Czornyj, L. A., Rocha, L., & Lazarowski, A. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-6355-3_8 · Cited by 4
Co-administration of erythropoietin and iron complex improves late-phase liver regeneration
Kim, J.-Y., Choi, D., Kim, J., Kim, Y., Lim, H., Sung, J. M., Lee, M., Choung, Y. J., Chang, J. H., & Jeong, M. A. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.3.160 · Cited by 4
“The hematopoietic growth factor erythropoietin (EPO) not only stimulates erythropoiesis in bone marrow (10) but also has other multiple functions, including anti-apoptotic and hepatoprotective actions (11).”
BackgroundBhushan, B., Singh, N. K., & Singh, R. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70442 · Cited by 3
Garg, N., & Kamal, C. M. (2025) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-025-10688-0 · Cited by 3
Debeljak, N., & Sytkowski, A. J. (2007) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a000863.01 · Cited by 3
Mayasari, N. (2023) · Jurnal Nutrisi Ternak Tropis dan Ilmu Pakan · doi:10.24198/jnttip.v5i1.47535 · Cited by 3
Nishida, A., Nishida, M., & Iehara, T. (2024) · International Journal of Urology · doi:10.1111/iju.15427 · Cited by 3
Brain Ischemic Injury in Rodents: The Protective Effect of EPO
Letourneur, A., Petit, E., Roussel, S., Touzani, O., & Bernaudin, M. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-308-4_5 · Cited by 4
Li, Y. H., Chen, S., & Chien, C. L. (2015) · Brain and Behavior · doi:10.1002/brb3.356 · Cited by 3
Syndromes myélodysplasiques érythroblastopéniques
Martinaud, C., Pons, S., Ménard, G., Gisserot, O., Jaureguiberry, J. P. D., & Brisou, P. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2010.07.009 · Cited by 3
Wen, Z., & Wang, P. (2012) · PubMed Central · doi:10.3969/j.issn.1673-5374.2012.08.003 · Cited by 5
“Erythropoietin prevents neuronal apoptosis induced by a variety of stimuli [14] .”
BackgroundEryrthropoietin and the promise of ischemic multiorgan protection*
Stevens, R. D., & Bhardwaj, A. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181810513 · Cited by 3
On Recombinant Human Erythropoietin Preventing the Death of Mice during Cerebral Malaria
Lackner, P., Helbok, R., & Schmutzhard, E. (2007) · The Journal of Infectious Diseases · doi:10.1086/513283 · Cited by 3
“observed in hematopoietic cells [6].”
The Protective Effect of Recombinant Human Erythropoietin against Cisplatin-Induced Ototoxicity
Doğan, E., Yılmaz, O., Bağrıyanık, A., Kıray, M., Ellıdokuz, H., Altun, Z. S., Aktaş, S., Erçetin, P., Kolatan, E., Kırkım, G., et al. (2014) · The Journal of International Advanced Otology · doi:10.5152/iao.2014.361 · Cited by 2
“Recently, EPO and its receptor have been shown to be present in several nonhematopoietic tissues, such as kidney, liver, brain, and heart [10, 11].”
BackgroundLiu, X., Zhang, D., Li, M., Ma, H., & Cai, J. (2025) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-025-02979-4 · Cited by 2
“Consequently, EPO has been identified as a systemic protective cytokine with pleiotropic biological functions [24].”
Koo, B., Shin, H., Jeon, S., Bang, J. H., Do, S.-H., & Na, H. (2024) · Korean Journal of Anesthesiology · doi:10.4097/kja.23789 · Cited by 2
Rational design of selective bispecific EPO-R/CD131 agonists
Doiron, K. E., Way, J. C., & Silver, P. A. (2025) · Protein Engineering Design and Selection · doi:10.1093/protein/gzaf013 · Cited by 2
Erythropoietin—A Hematopoietic Hormone with Emerging Diverse Activities
Prutchi‐Sagiv, S., Mittelman, M., & Neumann, D. (2006) · Elsevier eBooks · doi:10.1016/b978-012369442-3/50197-5 · Cited by 2
Role of Erythropoietin in Inflammatory Pathologies of the CNS
Ghezzi, P., Bigini, P., & Mengozzi, M. (2006) · Springer eBooks · doi:10.1007/978-0-387-30011-5_12 · Cited by 2
Self-citationErythropoietin Receptor Gene (EPOR) Polymorphisms are Associated with Sow Litter Sizes
Zhang, L., Wang, L., Li, Y., Yan, H., Zhao, K., & Wang, L. (2011) · Agricultural Sciences in China · doi:10.1016/s1671-2927(11)60078-3 · Cited by 2
Hassan, F. M., & Eid, D. (2020) · Bulletin of Egyptian Society for Physiological Sciences · doi:10.21608/besps.2020.25404.1047 · Cited by 2
“inhibiting FOXO3a (31) or stopping cytochrome c release (32).”
Fioranelli, M., & Guglielmo Marconi University (2015) · Clinical Case Reports and Reviews · doi:10.15761/ccrr.1000118 · Cited by 2
Production of human erythropoietin in transgenic canola employing the technology of oleosin fusion
Newman, C. N. (2013) · Lume (Universidade Federal do Rio Grande do Sul) · Cited by 2
Kim, T., Ji, J. W., Chang, H. G., Kim, M. O., Ryoo, Z. Y., Park, I. K., & Kim, S. J. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)13156-6 · Cited by 2
Gao, Y., Wang, C., Wang, Y., Zhao, X., Yao, Y., Wu, J., Wang, Y., Zhao, Z., & Shi, Y. (2026) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2026.101869 · Cited by 1
Sanghvi, G. V., Bellucci, S., Ballal, S., Ariffin, I. A., Singh, A., Sabarivani, A., Ray, S., Jain, B., Nainwal, P., & Deepak, A. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1708887 · Cited by 1
“…where impaired oxygen sensing and reduced EPO production lead to diminished erythroid progenitor survival and anemia, underscoring the essential role of EPO in maintaining erythropoietic homeostasis under stress conditions (Brines and Cerami, 2008; Ghezzi and Brines, 2004; Eschbach et al., 1989).”
Gazmuri, R. J., Ayoub, I. M., & Radhakrishnan, J. (2010) · Signa Vitae · doi:10.22514/sv52.112010.1 · Cited by 1
“However, several studies have recently shown that erythropoietin also activates potent cell survival mechanisms during ischemia and reperfusion through genomic and non-genomic signaling pathways in a broad array of organs and tissues including the heart, (61-66) brain, (67,68) spinal cord, (69) retina, (70) kidney, (7…”
BackgroundErythropoietin and Its Derivatives
Bogoslovsky, T., Bernstock, J. D., Kenney, K., Moore, C. B., & Diaz-Arrastia, R. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802686-1.00004-3 · Cited by 1
The Role of Erythropoietin-Derived Peptides in Tissue Protection
Zhang, C., & Yang, C. (2018) · InTech eBooks · doi:10.5772/intechopen.71931 · Cited by 1
Hubungan Kadar Serum Erithropoietin Dengan Transferin Pada Ibu Hamil Anemia Dan Ibu Hamil Normal
Satria, E., Amir, A., & Vaulinne, V. (2019) · Jurnal Kesehatan Andalas · doi:10.25077/jka.v8i2.995 · Cited by 1
Optic nerve avulsion: A case report
Gyenes, A., Sándor, G. L., Csákány, B., Récsán, Z., Rudas, G., Nagy, Z. Z., & Maka, E. (2021) · Developments in Health Sciences · doi:10.1556/2066.2020.00013 · Cited by 1
Klein, A., & Wahbi, W. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104731 · Cited by 1
From bench to bedside: Neuroprotective effects of erythropoietin
Ehrenreich, H., & Bartels, C. (2008) · Springer eBooks · doi:10.1007/978-3-211-69459-6_32 · Cited by 1
Liron, T., Nahari, T., Souroujon, M. C., & Neumann, D. (2010) · Biochemical Journal · doi:10.1042/bj20091951 · Cited by 1
The Endothelium of Basilar Artery of Diabetic Rat Treated With Epoetin Delta
Loesch, A., Tang, H., Cotter, M. A., & Cameron, N. E. (2009) · Angiology · doi:10.1177/0003319709348294 · Cited by 1
“Tissue-protective effects of EPO involve the activation of several protective pathways in target cells, including the prevention of apoptosis, restoration of vascular autoregulation, attenuation of inflammatory responses, and augmentation of restorative functions, such as direct recruitment of stem cells.(46)”
BackgroundEditorial: Erythropoietin and prenatal hypoxiaischemia
Gidday, J. M., & Park, T. S. (2010) · Journal of Neurosurgery Pediatrics · doi:10.3171/2010.4.peds10103 · Cited by 2
Pekle, E., Rosignoli, G., Smith, A., Grassi, L., Chris, Sellick, Pearce, C., Harris, C. L., & Smales, M. (2020) · BMC Proceedings · doi:10.1186/s12919-020-00188-y · Cited by 1
Baiula, M. (2008) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/687
Le, K. M., Klemm, K., Abshagen, K., Eipel, C., Menger, M. D., & Vollmar, B. (2007) · Langenbecks Archiv für Chirurgie. Supplement · doi:10.1007/978-3-540-71123-0_69
Current Advances in Cerebral Malaria Associated Encephalopathy
Liu, M., Guo, S., Battle, M., & Jonathan, K. (2012) · InTech eBooks · doi:10.5772/30739
“In other words, the non-hematopoietic function of Epo occurs in organs outside the bone marrow such as brain, retina, spinal cord, peripheral nerves, heart, kidney, and skin (Ghezzi and Brines 2004; Maiese, Li et al. 2005; Arcasoy 2008; Casals-Pascual, Idro et al. 2009).”
BackgroundChapter 7 Gene induction, protein synthesis, and related issues
Hakim, A. M., & Thompson, C. S. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(08)01907-6
Fevre, M. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
Minimising reperfusion injury in settings of myocardial ischaemia
Gazmuri, R. J. (2007) · Springer eBooks · doi:10.1007/88-470-0407-1_22
Kaiser, K., & Picot, S. (2007) · The Journal of Infectious Diseases · doi:10.1086/513285
Alexander, M. L. (2013) · OpenCommons - UConn (University of Connecticut)
Metadata
- Authors
- Ghezzi, P., & Brines, M.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Oswego Community Hospital (US)
- Corresponding author
- Ghezzi, P
- Venue
- Cell Death & Differentiation
- Published
- 2004-07
- Volume
- 11
- Issue
- S1
- Pages
- S37-S44
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W2121188367
- Cited by
- 327
- References
- 94
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 6 · 2023: 9 · 2022: 11 · 2021: 12 · 2020: 14 · 2019: 11 · 2018: 13 · 2017: 12 · 2016: 9 · 2015: 7 · 2014: 18 · 2013: 15 · 2012: 18
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutional Research information system (University of Urbino) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Keywords
- erythropoietin, neuroprotection, neuronal apoptosis, signaling pathways, erythroid progenitor cells, tissue protection, bone marrow erythropoiesis
- MeSH terms
- Animals, Anti-Inflammatory Agents, DNA-Binding Proteins, Epithelial Cells, Erythropoietin, Hematopoiesis, Humans, Inflammation, Kidney Tubules, Models, Biological, Neurons, Nuclear Proteins, Transcription Factors, Signal Transduction, Cytokines, Myocardial Ischemia, Apoptosis, Neuroprotective Agents, Cytoprotection, Trauma, Nervous System, Endothelial Cells, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.